Improving efficiency in clinical trials using auxiliary information: Application of a multi‐state cure model

DOI10.1111/BIOM.12281zbMATH Open1390.62245OpenAlexW2122192985WikidataQ41587108 ScholiaQ41587108MaRDI QIDQ3459944FDOQ3459944

Authors: A. S. C. Conlon, Daniel J. Sargent, Jeremy M. G. Taylor 

Publication date: 11 January 2016

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc4480062

Recommendations

• Improving Efficiency of Inferences in Randomized Clinical Trials Using Auxiliary Covariates
• scientific article; zbMATH DE number 2135398
• Approaches for Optimal Sequential Decision Analysis in Clinical Trials
• Bayesian design of clinical trials using joint cure rate models for longitudinal and time-to-event data
• Stochastic approximation and modern model-based designs for dose-finding clinical trials
• Using pilot study information to increase efficiency in clinical trials

zbMATH Keywords

multiple imputationauxiliary variablemulti-state modelcure modelscolon cancerKaplan-Meier estimates

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Estimation in multivariate analysis (62H12)

Cites Work

• Title not available (Why is that?)
• Multiple Imputation After 18+ Years
• A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker
• Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
• Title not available (Why is that?)
• Using Auxiliary Variables for Improved Estimates of Survival Time
• A shrinkage approach for estimating a treatment effect using intermediate biomarker data in clinical trials
• Some comments on efficiency gains from auxiliary information for right-censored data
• Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials
• Using surrogate failure time data to increase cost effectiveness in clinical trials

Cited In (3)

• A note on compatibility for inference with missing data in the presence of auxiliary covariates
• A Bayesian multi‐risks survival (MRS) model in the presence of double censorings
• Using categorical markers as auxiliary variables in log-rank tests and hazard ratio estimation

This page was built for publication: Improving efficiency in clinical trials using auxiliary information: Application of a multi‐state cure model

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3459944)